Visualization of drug target interactions in the contexts of pathways and networks with ReactomeFIViz [version 1; peer review: 2 approved]
The precision medicine paradigm is centered on therapies targeted to particular molecular entities that will elicit an anticipated and controlled therapeutic response. However, genetic alterations in the drug targets themselves or in genes whose products interact with the targets can affect how well...
Main Authors: | Aurora S. Blucher, Shannon K. McWeeney, Lincoln Stein, Guanming Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2019-06-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/8-908/v1 |
Similar Items
-
Automation of ReactomeFIViz via CyREST API [version 2; referees: 2 approved]
by: Fred Loney, et al.
Published: (2018-05-01) -
Natural Product Target Network Reveals Potential for Cancer Combination Therapies
by: Steven R. Chamberlin, et al.
Published: (2019-05-01) -
Reactome graph database: Efficient access to complex pathway data.
by: Antonio Fabregat, et al.
Published: (2018-01-01) -
Reactome: An integrated expert model of human molecular processes and access toolkit
by: Bono Bernard de, et al.
Published: (2007-12-01) -
Reactome from a WikiPathways Perspective.
by: Anwesha Bohler, et al.
Published: (2016-05-01)